Search by Drug Name or NDC

    NDC 25021-0174-16 daptomycin 50 mg/mL Details

    daptomycin 50 mg/mL

    daptomycin is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is DAPTOMYCIN.

    Product Information

    NDC 25021-0174
    Product ID 25021-174_a3f62ffc-f089-4f4c-bad1-99f60f1d88b0
    Associated GPIs 16270030002140
    GCN Sequence Number 053190
    GCN Sequence Number Description daptomycin VIAL 500 MG INTRAVEN
    HIC3 W9B
    HIC3 Description CYCLIC LIPOPEPTIDES
    GCN 20569
    HICL Sequence Number 025673
    HICL Sequence Number Description DAPTOMYCIN
    Brand/Generic Generic
    Proprietary Name daptomycin
    Proprietary Name Suffix n/a
    Non-Proprietary Name daptomycin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name DAPTOMYCIN
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207104
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0174-16 (25021017416)

    NDC Package Code 25021-174-16
    Billing NDC 25021017416
    Package 10 VIAL in 1 CARTON (25021-174-16) / 10 mL in 1 VIAL
    Marketing Start Date 2019-11-15
    NDC Exclude Flag N
    Pricing Information N/A